| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/12/2005 | WO2005023767A3 Diastereomers of 4-aryloxy-3-hydroxypiperidines |
| 05/12/2005 | WO2004048321A8 Phenylsulfoxide and phenylsulfone derivatives |
| 05/12/2005 | US20050101675 Benzamidine derivatives and process for production thereof |
| 05/12/2005 | US20050101644 Benzylether amine compounds useful as CCR-5 antagonists |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101610 Antiischemic agents; brain disorders; cardiovascular disorders; for the alleviation or treatment of symptoms due to neurodegenerative diseases and symptoms derived from diabetes, arteriosclerosis and inflammatory diseases ; for example, N-tert-butoxycarbonyl-4-[4-(4-fluorophenoxy)phenyl]-4-piperidinol |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | US20050100572 Gelling agent for oil |
| 05/12/2005 | CA2544772A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 05/12/2005 | CA2544763A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 05/12/2005 | CA2544350A1 N-substituted benzene sulfonamides |
| 05/12/2005 | CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | CA2543089A1 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications |
| 05/12/2005 | CA2540843A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1001771B1 A medicament against endometriosis-associated infertility |
| 05/11/2005 | CN1615297A Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 05/10/2005 | US6891008 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides |
| 05/10/2005 | US6890949 Amino ceramide-like compounds and therapeutic methods of use |
| 05/10/2005 | US6890944 Organic acid salt of amlodipine |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890936 Muscarinic antagonists |
| 05/10/2005 | US6890932 Anthranilic acid derivative |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890921 Selectively inhibit binding to alpha-1a adrenergic receptor; 1-(2-phthalimidoethyl)-4-(2-isopropyloxyphenyl)piperazine; N-(Ethyl-2-(2-iso-propyloxyphenyl)piperazin-4-yl))-(1'-(2-oxy -piperdinyl))acetamidemide |
| 05/06/2005 | WO2005040120A1 Tetrahydropyridine derivatives |
| 05/06/2005 | WO2005040119A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005040118A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| 05/06/2005 | WO2005040108A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective mao-b inhibitors |
| 05/06/2005 | WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2540543A1 Tetrahydropyridine derivatives |
| 05/05/2005 | US20050096478 Derivatives of fluoro(hydro)carbons attached to an -alkylene-oxy-carbonyl-leaving group; reactive with amine-containing compounds to form a fluoro-substituted carbamyl protective group useful for the efficient separation, recovery and purification of synthsized organic compounds; libraries |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096466 Process for the preparation of tetrazol-derived compounds as growth hormone secretagogues |
| 05/05/2005 | US20050096359 melanocortin receptor agonist, antagonist; preventing or treating inflammatory diseases, AIDS, obesity, bulimia, anorexia or sexual dysfunction; N-(2-aminoethyl)-3'-[1-{N-(1-benzylpiperidin-4-yl)-N-(2-naphthylacetyl)aminoethyl][1,1'-biphenyl)-2-carboxamide dihydrochloride |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096328 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 05/05/2005 | US20050096326 4-(4-methylpiperazin-1-yl)4V-(4-morpholinophenyl)-indan-2-carboxamide; h5-HT1B receptor antagonist; serotonin-mediated disorders; oral bioavailability |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050092452 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products |
| 05/04/2005 | EP1528056A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527129A1 Beta-nucleating, light stabilizing agents for polypropylene |
| 05/04/2005 | EP1527048A2 N- phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/04/2005 | EP1140830B1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity |
| 05/04/2005 | EP1032368B1 Iontophoretic devices comprising piperidin derivatives |
| 05/04/2005 | EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | EP0755923B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 05/04/2005 | CN1199945C Method for producing cyclic lactams |
| 05/03/2005 | US6887889 Aryl and biaryl piperdines with MCH modulatory activity |
| 05/03/2005 | US6887887 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 05/03/2005 | US6887886 Therapeutic compositions comprising excess enantiomer |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2390636C Stabilized formulations comprising amlodipine maleate |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037782A2 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/28/2005 | WO2005037755A2 Bridged ring structures as pharmaceutical agents |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005036961A2 N-substituted azacycles |
| 04/28/2005 | WO2004089293A3 Hydroxamic acid compounds and methods of use thereof |
| 04/28/2005 | WO2004083170A3 Compounds, a process for their preparation and their use as dyes and pigments |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090528 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090478 Platinum complexes and their use in cancer treatment |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2542925A1 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | CA2542373A1 Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/28/2005 | CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1524976A1 A non-hormonal approach to male contraception |
| 04/27/2005 | EP1423367B1 Solvates of lercanidipine hydrochloride and crystalline forms of lercanidipine hydrochloride |
| 04/27/2005 | EP1144360B1 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 04/27/2005 | EP0942733B1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 04/27/2005 | CN1610676A Compounds and method for the treatment of overactive bladder |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610665A Process for preparation of cyanophenylbenzoic acid derivatives |
| 04/27/2005 | CN1609102A Optically active amlodipine resolving process |